These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19109069)

  • 1. Pharmacological targets revealed by myocardial postconditioning.
    Burley DS; Baxter GF
    Curr Opin Pharmacol; 2009 Apr; 9(2):177-88. PubMed ID: 19109069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postconditioning: from the bench to bedside.
    Cour M; Gomez L; Mewton N; Ovize M; Argaud L
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):117-30. PubMed ID: 20938041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury.
    Vinten-Johansen J; Zhao ZQ; Zatta AJ; Kin H; Halkos ME; Kerendi F
    Basic Res Cardiol; 2005 Jul; 100(4):295-310. PubMed ID: 15793629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of B-cell lymphoma 2 protein, an antiapoptotic regulator of mitochondrial permeability transition, on isoflurane-induced and ischemic postconditioning in rabbits.
    Wang C; Neff DA; Krolikowski JG; Weihrauch D; Bienengraeber M; Warltier DC; Kersten JR; Pagel PS
    Anesth Analg; 2006 May; 102(5):1355-60. PubMed ID: 16632808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial permeability transition pore and postconditioning.
    Gateau-Roesch O; Argaud L; Ovize M
    Cardiovasc Res; 2006 May; 70(2):264-73. PubMed ID: 16581044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism by which ischemic postconditioning reduces reperfusion arrhythmias in rats remains elusive.
    Dow J; Bhandari A; Kloner RA
    J Cardiovasc Pharmacol Ther; 2009 Jun; 14(2):99-103. PubMed ID: 19461101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.
    Heusch G
    Compr Physiol; 2015 Jul; 5(3):1123-45. PubMed ID: 26140711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postconditioning: reduction of reperfusion-induced injury.
    Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning and postconditioning: united at reperfusion.
    Hausenloy DJ; Yellon DM
    Pharmacol Ther; 2007 Nov; 116(2):173-91. PubMed ID: 17681609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology and pharmacology of myocardial preconditioning and postconditioning.
    Huffmyer J; Raphael J
    Semin Cardiothorac Vasc Anesth; 2009 Mar; 13(1):5-18. PubMed ID: 19329471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial protection in reperfusion with postconditioning.
    Vinten-Johansen J; Zhao ZQ; Jiang R; Zatta AJ
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1035-45. PubMed ID: 16292995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological pre- and post- conditioning agents: reperfusion-injury of the heart revisited.
    Andreadou I; Iliodromitis EK; Koufaki M; Kremastinos DT
    Mini Rev Med Chem; 2008 Aug; 8(9):952-9. PubMed ID: 18691153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis.
    Cohen MV; Yang XM; Downey JM
    Circulation; 2007 Apr; 115(14):1895-903. PubMed ID: 17389262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection: chances and challenges of its translation to the clinic.
    Heusch G
    Lancet; 2013 Jan; 381(9861):166-75. PubMed ID: 23095318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postconditioning: lethal reperfusion injury as a therapeutic target].
    Ovize M
    Ann Cardiol Angeiol (Paris); 2006 Apr; 55(2):66-9. PubMed ID: 16708988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo.
    Huhn R; Heinen A; Weber NC; Kerindongo RP; Oei GT; Hollmann MW; Schlack W; Preckel B
    J Pharmacol Exp Ther; 2009 May; 329(2):600-7. PubMed ID: 19244549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.